{"entity":{"type":"insider","cik":"0001782962","url":"/insider/0001782962","json_url":"/insider/0001782962.json","name":"Poulton Jeffrey V.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":123,"n_filings":15,"first":"2023-04-28","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Poulton Jeffrey V.","source":"filing","n_filings":15,"first_seen":"2023-04-28","last_seen":"2026-03-06"}],"transactions":[{"id":5988455,"accession":"0001735276-26-000061","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000061","line_url":"/filing/0001735276-26-000061","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2468.0,"shares_display":"2,468","price_per_share":323.07558346839545,"price_display":"323.08","price_state":"stated","total_value":797350.54,"total_display":"797,350.54","total_whole":"797,351","shares_owned_after":62319.0,"shares_owned_after_display":"62,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":8},{"id":5788681,"accession":"0001735276-26-000053","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000053","line_url":"/filing/0001735276-26-000053","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2206.0,"shares_display":"2,206","price_per_share":327.6522121486854,"price_display":"327.65","price_state":"stated","total_value":722800.78,"total_display":"722,800.78","total_whole":"722,801","shares_owned_after":65393.0,"shares_owned_after_display":"65,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":10},{"id":5899385,"accession":"0001735276-26-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000025","line_url":"/filing/0001735276-26-000025#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2242.0,"shares_display":"2,242","price_per_share":310.0808,"price_display":"310.08","price_state":"stated","total_value":695201.1536,"total_display":"695,201.15","total_whole":"695,201","shares_owned_after":59802.0,"shares_owned_after_display":"59,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-17","scope":"insider"},{"id":6140502,"accession":"0001735276-26-000013","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001735276-26-000013","line_url":"/filing/0001735276-26-000013","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2780.0,"shares_display":"2,780","price_per_share":362.86542086330934,"price_display":"362.87","price_state":"stated","total_value":1008765.87,"total_display":"1,008,765.87","total_whole":"1,008,766","shares_owned_after":58004.0,"shares_owned_after_display":"58,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider","n_lines":21},{"id":4743752,"accession":"0001735276-25-000117","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":869.0,"shares_display":"869","price_per_share":452.69,"price_display":"452.69","price_state":"stated","total_value":393387.61,"total_display":"393,387.61","total_whole":"393,388","shares_owned_after":55087.0,"shares_owned_after_display":"55,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743750,"accession":"0001735276-25-000117","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":704.0,"shares_display":"704","price_per_share":450.81,"price_display":"450.81","price_state":"stated","total_value":317370.24,"total_display":"317,370.24","total_whole":"317,370","shares_owned_after":56388.0,"shares_owned_after_display":"56,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743748,"accession":"0001735276-25-000117","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":432.0,"shares_display":"432","price_per_share":451.86,"price_display":"451.86","price_state":"stated","total_value":195203.52,"total_display":"195,203.52","total_whole":"195,204","shares_owned_after":55956.0,"shares_owned_after_display":"55,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743744,"accession":"0001735276-25-000117","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":428.0,"shares_display":"428","price_per_share":453.77,"price_display":"453.77","price_state":"stated","total_value":194213.56,"total_display":"194,213.56","total_whole":"194,214","shares_owned_after":54659.0,"shares_owned_after_display":"54,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743742,"accession":"0001735276-25-000117","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":324.0,"shares_display":"324","price_per_share":449.79,"price_display":"449.79","price_state":"stated","total_value":145731.96,"total_display":"145,731.96","total_whole":"145,732","shares_owned_after":57092.0,"shares_owned_after_display":"57,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743740,"accession":"0001735276-25-000117","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":317.0,"shares_display":"317","price_per_share":454.84,"price_display":"454.84","price_state":"stated","total_value":144184.28,"total_display":"144,184.28","total_whole":"144,184","shares_owned_after":54342.0,"shares_owned_after_display":"54,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743738,"accession":"0001735276-25-000117","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":234.0,"shares_display":"234","price_per_share":448.77,"price_display":"448.77","price_state":"stated","total_value":105012.18,"total_display":"105,012.18","total_whole":"105,012","shares_owned_after":57416.0,"shares_owned_after_display":"57,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743737,"accession":"0001735276-25-000117","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191.0,"shares_display":"191","price_per_share":457.43,"price_display":"457.43","price_state":"stated","total_value":87369.13,"total_display":"87,369.13","total_whole":"87,369","shares_owned_after":54056.0,"shares_owned_after_display":"54,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743736,"accession":"0001735276-25-000117","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":446.53,"price_display":"446.53","price_state":"stated","total_value":66979.5,"total_display":"66,979.50","total_whole":"66,980","shares_owned_after":57723.0,"shares_owned_after_display":"57,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4743735,"accession":"0001735276-25-000117","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-25-000117","line_url":"/filing/0001735276-25-000117#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001782962","owner_name":"Poulton Jeffrey V.","owner_display_name":"Poulton Jeffrey V.","owner_url":"/insider/0001782962","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95.0,"shares_display":"95","price_per_share":455.82,"price_display":"455.82","price_state":"stated","total_value":43302.9,"total_display":"43,302.90","total_whole":"43,303","shares_owned_after":54247.0,"shares_owned_after_display":"54,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"}],"collapsed":true,"next_cursor":"2025-10-02|4743735","ledger_fault":false,"count":{"value":123,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":123,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":123},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (EVP, Chief Financial Officer)","n_filings":15,"first_seen":"2023-04-28","last_seen":"2026-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001782962","retrieved_at":"2026-08-26T08:23:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}